<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">30485760</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1545-1585</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>81</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
              <Day>10</Day>
            </PubDate>
          </JournalIssue>
          <Title>Annual review of physiology</Title>
          <ISOAbbreviation>Annu Rev Physiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Branched Chain Amino Acids.</ArticleTitle>
        <Pagination>
          <StartPage>139</StartPage>
          <EndPage>164</EndPage>
          <MedlinePgn>139-164</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1146/annurev-physiol-020518-114455</ELocationID>
        <Abstract>
          <AbstractText>Branched chain amino acids (BCAAs) are building blocks for all life-forms. We review here the fundamentals of BCAA metabolism in mammalian physiology. Decades of studies have elicited a deep understanding of biochemical reactions involved in BCAA catabolism. In addition, BCAAs and various catabolic products act as signaling molecules, activating programs ranging from protein synthesis to insulin secretion. How these processes are integrated at an organismal level is less clear. Inborn errors of metabolism highlight the importance of organismal regulation of BCAA physiology. More recently, subtle alterations of BCAA metabolism have been suggested to contribute to numerous prevalent diseases, including diabetes, cancer, and heart failure. Understanding the mechanisms underlying altered BCAA metabolism and how they contribute to disease pathophysiology will keep researchers busy for the foreseeable future.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Neinast</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA; email: zarany@pennmedicine.upenn.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Murashige</LastName>
            <ForeName>Danielle</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA; email: zarany@pennmedicine.upenn.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arany</LastName>
            <ForeName>Zoltan</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA; email: zarany@pennmedicine.upenn.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>F30 HL142186</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK107667</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK114103</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 GM007229</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Annu Rev Physiol</MedlineTA>
        <NlmUniqueID>0370600</NlmUniqueID>
        <ISSNLinking>0066-4278</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000597">Amino Acids, Branched-Chain</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000597" MajorTopicYN="N">Amino Acids, Branched-Chain</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">branched chain amino acids</Keyword>
        <Keyword MajorTopicYN="Y">cancer</Keyword>
        <Keyword MajorTopicYN="Y">catabolism</Keyword>
        <Keyword MajorTopicYN="Y">diabetes</Keyword>
        <Keyword MajorTopicYN="Y">heart disease</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30485760</ArticleId>
        <ArticleId IdType="mid">NIHMS1030933</ArticleId>
        <ArticleId IdType="pmc">PMC6536377</ArticleId>
        <ArticleId IdType="doi">10.1146/annurev-physiol-020518-114455</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Davis TA, Fiorotto ML, Reeds PJ. 1993. 
Amino acid compositions of body and milk protein change during the suckling period in rats. J. Nutr
123(5):947–56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8487106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harper A, Block K, Cree T. 1983. 
Branched-chain amino acids: nutritional and metabolic interrelationships In Proceedings of the Fourth Symposium on Protein Metabolism and Nutrition, ed. Pion R, Arnal M, Bonin D, pp. 159–81. Paris: INRA</Citation>
        </Reference>
        <Reference>
          <Citation>Moura A, Savageau MA, Alves R. 2013. 
Relative amino acid composition signatures of organisms and environments. PLOS ONE
8(10):e77319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3808408</ArticleId>
            <ArticleId IdType="pubmed">24204807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chou PY, Fasman GD. 1973. 
Structural and functional role of leucine residues in proteins. J. Mol. Biol
74(3):263–81</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4692853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dill KA. 1990. 
Dominant forces in protein folding. Biochemistry
29(31):7133–55</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2207096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schweigert BS, Bennett BA, Guthneck BT. 1954. 
Amino acid composition of organ meats. J. Food Sci
19(1–6):219–23</Citation>
        </Reference>
        <Reference>
          <Citation>Brosnan JT, Brosnan ME. 2006. 
Branched-chain amino acids: enzyme and substrate regulation. J. Nutr
136(1):207S–11S</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16365084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimomura Y, Obayashi M, Murakami T, Harris RA. 2001. 
Regulation of branched-chain amino acid catabolism: nutritional and hormonal regulation of activity and expression of the branched-chain α-keto acid dehydrogenase kinase. Curr. Opin. Clin. Nutr. Metab. Care
4(5):419–23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11568504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCourt JA, Duggleby RG. 2006. 
Acetohydroxyacid synthase and its role in the biosynthetic pathway for branched-chain amino acids. Amino Acids
31(2):173–210</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16699828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amorim Franco TM, Blanchard JS. 2017. 
Bacterial branched-chain amino acid biosynthesis: structures, mechanisms, and drugability. Biochemistry
56(44):5849–65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5839172</ArticleId>
            <ArticleId IdType="pubmed">28977745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ichihara A, Koyama E. 1966. 
Transaminase of branched chain amino acids. J. Biochem
59(2):160–69</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5943594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ichihara A, Yamasaki Y, Masuji H, Sato J. 1975. 
Isozyme patterns of branched chain amino acid transaminase during cellular differentiation and carcinogenesis In Isozymes, Vol. 3, ed. Markert CL, pp. 875–89. Amsterdam: Elsevier</Citation>
        </Reference>
        <Reference>
          <Citation>Kadowaki H, Knox WE. 1982. 
Cytoslic and mitochondrial isoenzymes of branched-chain amino acid aminotransferase during development of the rat. Biochem. J
202:777–83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1158175</ArticleId>
            <ArticleId IdType="pubmed">7092844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krebs HA, Lund P. 1977. 
Aspects of the regulation of the metabolism of branched-chain amino acids. Adv. Enzyme Regul
15:375–94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goto M, Shinno H, Ichihara A. 1977. 
Isozyme patterns of branched-chain amino acid transaminase in human tissues and tumors. GANN Jpn. J. Cancer Res
68(5):663–67</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">201538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel MS, Nemeria NS, Furey W, Jordan F. 2014. 
The pyruvate dehydrogenase complexes: structure-based function and regulation. J. Biol. Chem
289(24):16615–23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4059105</ArticleId>
            <ArticleId IdType="pubmed">24798336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wieland OH. 1983. 
The mammalian pyruvate dehydrogenase complex: structure and regulation In Reviews of Physiology, Biochemistry and Pharmacology, Vol. 96, ed. Adrian RH, zur Hausen H, Helmreich E, Holzer H, Jung R, et al., pp. 123–70. Berlin: Springer</Citation>
        </Reference>
        <Reference>
          <Citation>Johnson WA, Connelly JL, Glynn MT. 1972. 
Cellular localization and characterization of bovine liver branched-chain α-keto acid dehydrogenases. Biochemistry
11(10):1967–73</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4337197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paxton R, Harris RA. 1982. 
Isolation of rabbit liver branched chain α-ketoacid dehydrogenase and regulation by phosphorylation. J. Biol. Chem
257(3):14433–39</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7142221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pettit FH, Yeaman SJ, Reed LJ. 1978. 
Purification and characterization of branched chain α-keto acid dehydrogenase complex of bovine kidney. PNAS
75(10):4881–85</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC336225</ArticleId>
            <ArticleId IdType="pubmed">283398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Danner DJ, Lemmon SK, Elsas LJ II. 1978. 
Substrate specificity and stabilization by thiamine pyrophosphate of rat liver branched chain α-ketoacid dehydrogenase. Biochem. Med
19(1):27–38</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">203270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Babady NE, Pang Y-P, Elpeleg O, Isaya G. 2007. 
Cryptic proteolytic activity of dihydrolipoamide dehydrogenase. PNAS
104(15):6158–63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1851069</ArticleId>
            <ArticleId IdType="pubmed">17404228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris RA, Popov KM, Shimomura Y, Zhao Y, Jaskiewicz J, et al.
1992. 
Purification, characterization, regulation and molecular cloning of mitochondrial protein kinases. Adv. Enzyme Regul
32:267–84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1496922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Popov KM, Shimomura Y, Harris RA. 1991. 
Purification and comparative study of the kinases specific for branched chain α-ketoacid dehydrogenase and pyruvate dehydrogenase. Protein Expr. Purif
2(4):278–86</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1821799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Popov KM, Zhao Y, Shimomura Y, Kuntz MJ, Harris RA. 1992. 
Branched-chain α-ketoacid dehydrogenase kinase. Molecular cloning, expression, and sequence similarity with histidine protein kinases. J. Biol. Chem
267(19):13127–30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1377677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimomura Y, Nanaumi N, Suzuki M, Popov KM, Harris RA. 1990. 
Purification and partial characterization of branched-chain α-ketoacid dehydrogenase kinase from rat liver and rat heart. Arch. Biochem. Biophys
283(2):293–99</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2177326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tuor U, Simone C, Bascaramurty S. 1992. 
Local blood-brain barrier in the newborn rabbit: postnatal changes in α-aminoisobutyric acid transfer within medulla, cortex, and selected brain areas. J. Neurochem
59(3):999–1007</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1494922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Damuni Z, Reed LJ. 1987. 
Purification and properties of the catalytic subunit of the branched-chain α-keto acid dehydrogenase phosphatase from bovine kidney mitochondria. J. Biol. Chem
262(11):5129–32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3031042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Damuni Z, Merryfield ML, Humphreys JS, Reed LJ. 1984. 
Purification and properties of branched-chain α-keto acid dehydrogenase phosphatase from bovine kidney. PNAS
81(14):4335–38</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC345583</ArticleId>
            <ArticleId IdType="pubmed">6589597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crowell PL, Block KP, Repa JJ, Torres N, Nawabi MD, et al.
1990. 
High branched-chain α-keto acid intake, branched chain α-keto acid dehydrogenase activity, and plasma and brain amino acid and plasma keto acid concentrations in rats. Am. J. Clin. Nutr
52(2):313–19</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2375298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frick G, Tai L, Blinder L, Goodman H. 1981. 
l-leucine activates branched chain α-keto acid dehydrogenase in rat adipose tissue. J. Biol. Chem
256(6):2618–20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7009595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lau KS, Fatania HR, Randle PJ. 1982. 
Regulation of the branched chain 2-oxoacid dehydrogenase kinase reaction. FEBS Lett
144(1):57–62</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6980796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Waymack P, DeBuysere M, Olson M. 1980. 
Studies on the activation and inactivation of the branched chain α-keto acid dehydrogenase in the perfused rat heart. J. Biol. Chem
255(20):9773–81</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7430101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Islam MM, Nautiyal M, Wynn RM, Mobley JA, Chuang DT, Hutson SM. 2010. 
Branched-chain amino acid metabolon, interaction of glutamate dehydrogenase with the mitochondrial branched-chain amino-transferase (BCATm). J. Biol. Chem
285(1):265–76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2804173</ArticleId>
            <ArticleId IdType="pubmed">19858196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Green CR, Wallace M, Divakaruni AS, Phillips SA, Murphy AN, et al.
2016. 
Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis. Nat. Chem. Biol
12(1):15–21</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4684771</ArticleId>
            <ArticleId IdType="pubmed">26571352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liebich HM, Först C. 1984. 
Hydroxycarboxylic and oxocarboxylic acids in urine: products from branched-chain amino acid degradation and from ketogenesis. J. Chromatogr. B Biomed. Sci. Appl
309:225–42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6434570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson KA, Huynh FK, Fisher-Wellman K, Stuart JD, Peterson BS, et al.
2017. 
SIRT4 is a lysine deacylase that controls leucine metabolism and insulin secretion. Cell Metab
25(4):838–55</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5444661</ArticleId>
            <ArticleId IdType="pubmed">28380376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones JM, Morrell JC, Gould SJ. 2000. 
Identification and characterization of HAOX1, HAOX2, and HAOX3, three human peroxisomal 2-hydroxy acid oxidases. J. Biol. Chem
275(17):12590–97</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10777549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Koevering M, Nissen S. 1992. 
Oxidation of leucine and alpha-ketoisocaproate to beta-hydroxy-beta-methylbutyrate in vivo. Am. J. Physiol. Endocrinol. Metab
262(1):E27–31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1733247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Long JZ, Svensson KJ, Bateman LA, Lin H, Kamenecka T, et al.
2016. 
The secreted enzyme PM20D1 regulates lipidated amino acid uncouplers of mitochondria. Cell
166(2):424–35</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4947008</ArticleId>
            <ArticleId IdType="pubmed">27374330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crown SB, Marze N, Antoniewicz MR. 2015. 
Catabolism of branched chain amino acids contributes significantly to synthesis of odd-chain and even-chain fatty acids in 3T3-L1 adipocytes. PLOS ONE
10(12):e0145850.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4692509</ArticleId>
            <ArticleId IdType="pubmed">26710334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallace M, Green CR, Roberts LS, Lee YM, McCarville JL, et al.
2018. 
Enzyme promiscuity drives branched-chain fatty acid synthesis in adipose tissues. Nat. Chem. Biol
14:1021–31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6245668</ArticleId>
            <ArticleId IdType="pubmed">30327559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mika A, Stepnowski P, Kaska L, Proczko M, Wisniewski P, et al.
2016. 
A comprehensive study of serum odd- and branched-chain fatty acids in patients with excess weight: odd- and branched-chain fatty acids in obesity. Obesity
24(8):1669–76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27355152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ran-Ressler RR, Devapatla S, Lawrence P, Brenna JT. 2008. 
Branched chain fatty acids are constituents of the normal healthy newborn gastrointestinal tract. Pediatr. Res
64(6):605–9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2662770</ArticleId>
            <ArticleId IdType="pubmed">18614964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buse MG, Reid SS. 1975. 
Leucine. A possible regulator of protein turnover in muscle. J. Clin. Investig
56(5):1250–61</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC301988</ArticleId>
            <ArticleId IdType="pubmed">1237498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang Hong S-O, Layman DK. 1984. 
Effects of leucine on in vitro protein synthesis and degradation in rat skeletal muscles. J. Nutr
114(7):1204–12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6737085</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li JB, Jefferson LS. 1978. 
Influence of amino acid availability on protein turnover in perfused skeletal muscle. Biochim. Biophys. Acta
544(2):351–59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">719005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfson RL, Chantranupong L, Saxton RA, Shen K, Scaria SM, et al.
2015. 
Sestrin2 is a leucine sensor for the mTORC1 pathway. Science
351:43–48</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4698017</ArticleId>
            <ArticleId IdType="pubmed">26449471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saxton RA, Knockenhauer KE, Wolfson RL, Chantranupong L, Pacold ME, et al.
2016. 
Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway. Science
351(6268):53–58</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4698039</ArticleId>
            <ArticleId IdType="pubmed">26586190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonfils G, Jaquenoud M, Bontron S, Ostrowicz C, Ungermann C, De Virgilio C. 2012. 
Leucyl-tRNA synthetase controls TORC1 via the EGO complex. Mol. Cell
46(1):105–10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22424774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han JM, Jeong SJ, Park MC, Kim G, Kwon NH, et al.
2012. 
Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell
149(2):410–24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22424946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoon M-S, Son K, Arauz E, Han JM, Kim S, Chen J. 2016. 
Leucyl-tRNA synthetase activates Vps34 in amino acid-sensing mTORC1 signaling. Cell Rep
16(6):1510–17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4981521</ArticleId>
            <ArticleId IdType="pubmed">27477288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Efeyan A, Zoncu R, Sabatini DM. 2012. 
Amino acids and mTORC1: from lysosomes to disease. Trends Mol. Med
18(9):524–33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3432651</ArticleId>
            <ArticleId IdType="pubmed">22749019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jewell JL, Russell RC, Guan K-L. 2013. 
Amino acid signalling upstream of mTOR. Nat. Rev. Mol. Cell Biol
14(3):133–39</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3988467</ArticleId>
            <ArticleId IdType="pubmed">23361334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laplante M, Sabatini DM. 2012. 
mTOR signaling in growth control and disease. Cell
149(2):274–93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3331679</ArticleId>
            <ArticleId IdType="pubmed">22500797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfson RL, Sabatini DM. 2017. 
The dawn of the age of amino acid sensors for the mTORC1 pathway. Cell Metab
26(2):301–9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5560103</ArticleId>
            <ArticleId IdType="pubmed">28768171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Christensen HN, Hellman B, Sehlin J, Tager HS, Täljedal I-B. 1971. 
In vitro stimulation of insulin release by non-metabolizable, transport-specific amino acids. Biochim. Biophys. Acta Biomembr
241(2):341–48</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4110546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fajans SS, Quibrera R, Pek S, Floyd J, Christensen HN, et al.
1971. 
Stimulation of insulin release in the dog by a nonmetabolizable amino acid. Comparison with leucine and arginine. J. Clin. Endocrinol. Metab
33(1):35–41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4934141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sener A, Malaisse WJ. 1980. 
l-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature
288(5787):187–89</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7001252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao ZY, Li G, Najafi H, Wolf BA, Matschinsky FM. 1999. 
Glucose regulation of glutaminolysis and its role in insulin secretion. Diabetes
48(8):1535–42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10426370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson DF, Cember ATJ, Matschinsky FM. 2018. 
Glutamate dehydrogenase: role in regulating metabolism and insulin release in pancreatic β-cells. J. Appl. Physiol
125(2):419–28</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29648519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stanley CA, Lieu YK, Hsu BYL, Burlina AB, Greenberg CR, et al.
1998. 
Hyperinsulinism and hyper-ammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N. Engl. J. Med
338(19):1352–57</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9571255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao Z, Young RA, Li G, Najafi H, Buettger C, et al.
2003. 
Distinguishing features of leucine and α-ketoisocaproate sensing in pancreatic β-cells. Endocrinology
144(5):1949–57</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12697702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bränström R, Efendic S, Berggren P-O, Larsson O. 1998. 
Direct inhibition of the pancreatic β-cell ATP-regulated potassium channel by α-ketoisocaproate. J. Biol. Chem
273(23):14113–18</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9603910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jang C, Oh SF, Wada S, Rowe GC, Liu L, et al.
2016. 
A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat. Med
22(4):421–26</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4949205</ArticleId>
            <ArticleId IdType="pubmed">26950361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts LD, Boström P, O’Sullivan JF, Schinzel RT, Lewis GD, et al.
2014. 
β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab
19(1):96–108</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4017355</ArticleId>
            <ArticleId IdType="pubmed">24411942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kitase Y, Vallejo JA, Gutheil W, Vemula H, Jähn K, et al.
2018. 
β-Aminoisobutyric acid, l -BAIBA, is a muscle-derived osteocyte survival factor. Cell Rep
22(6):1531–44</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5832359</ArticleId>
            <ArticleId IdType="pubmed">29425508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi C-X, Zhao M-X, Shu X-D, Xiong X-Q, Wang J-J, et al.
2016. 
β-Aminoisobutyric acid attenuates hepatic endoplasmic reticulum stress and glucose/lipid metabolic disturbance in mice with type 2 diabetes. Sci. Rep
6:21924.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4764829</ArticleId>
            <ArticleId IdType="pubmed">26907958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jung TW, Park HS, Choi GH, Kim D, Lee T. 2018. 
β-Aminoisobutyric acid attenuates LPS-induced inflammation and insulin resistance in adipocytes through AMPK-mediated pathway. J. Biomed. Sci
25(1):27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5875012</ArticleId>
            <ArticleId IdType="pubmed">29592806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Everman S, Mandarino LJ, Carroll CC, Katsanos CS. 2015. 
Effects of acute exposure to increased plasma branched-chain amino acid concentrations on insulin-mediated plasma glucose turnover in healthy young subjects. PLOS ONE
10(3):e0120049.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4363593</ArticleId>
            <ArticleId IdType="pubmed">25781654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Louard RJ, Barrett EJ, Gelfand RA. 1990. 
Effect of infused branched-chain amino acids on muscle and whole-body amino acid metabolism in man. Clin. Sci
79(5):457–66</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2174312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wahren J, Felig P, Hagenfeldt L. 1976. 
Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus. J. Clin. Investig
57(4):987–99</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC436742</ArticleId>
            <ArticleId IdType="pubmed">947963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grimble G
2000. 
Mechanisms of peptide and amino acid transport and their regulation In Proteins, Peptides and Amino Acids in Enteral Nutrition, ed. Fürst P, Young V, pp. 63–88. Basel: Karger</Citation>
        </Reference>
        <Reference>
          <Citation>Boirie Y, Dangin M, Gachon P, Vasson M-P, Maubois J-L, Beaufrère B. 1997. 
Slow and fast dietary proteins differently modulate postprandial protein accretion. PNAS
94(26):14930–35</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC25140</ArticleId>
            <ArticleId IdType="pubmed">9405716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dangin M, Boirie Y, Garcia-Rodenas C, Gachon P, Fauquant J, et al.
2001. 
The digestion rate of protein is an independent regulating factor of postprandial protein retention. Am. J. Physiol. Endocrinol. Metab
280(2):E340–48</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11158939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfe RR, Cifelli AM, Kostas G, Kim I-Y. 2017. 
Optimizing protein intake in adults: interpretation and application of the recommended dietary allowance compared with the acceptable macronutrient distribution range. Adv. Nutr. Int. Rev. J
8(2):266–75</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5347101</ArticleId>
            <ArticleId IdType="pubmed">28298271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fulgoni VL. 2008. 
Current protein intake in America: analysis of the National Health and Nutrition Examination Survey, 2003–2004. Am. J. Clin. Nutr
87(5):1554S–57S</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18469286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bier DM. 1989. 
Intrinsically difficult problems: the kinetics of body proteins and amino acids in man. Diabetes/Metab. Rev
5(2):111–32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2647431</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hui S, Ghergurovich JM, Morscher RJ, Jang C, Teng X, et al.
2017. 
Glucose feeds the TCA cycle via circulating lactate. Nature
551:115–18</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5898814</ArticleId>
            <ArticleId IdType="pubmed">29045397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matthews DE, Motil KJ, Rohrbaugh DK, Burke JF, Young VR, Bier DM. 1980. 
Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1-13C] leucine. Am. J. Physiol. Endocrinol. Metab
238(5):E473–79</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6769340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfe RR, Goodenough RD, Wolfe MH, Royle GT, Nadel ER. 1982. 
Isotopic analysis of leucine and urea metabolism in exercising humans. J. Appl. Physiol
52(2):458–66</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7061300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Short KR, Vittone JL, Bigelow ML, Proctor DN, Nair KS. 2004. 
Age and aerobic exercise training effects on whole body and muscle protein metabolism. Am. J. Physiol. Endocrinol. Metab
286(1):E92–101</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14506079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Waterlow JC. 2006. 
Protein Turnover
Wallingford, UK: CABI</Citation>
        </Reference>
        <Reference>
          <Citation>May ME, Buse MG. 1989. 
Effects of branched-chain amino acids on protein turnover. Diabetes/Metab. Rev
5(3):227–45</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2656154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anthony JC, Yoshizawa F, Anthony TG, Vary TC, Jefferson LS, Kimball SR. 2000. 
Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J. Nutr
130(10):2413–19</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11015466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anthony JC, Lang CH, Crozier SJ, Anthony TG, MacLean DA, et al.
2002. 
Contribution of insulin to the translational control of protein synthesis in skeletal muscle by leucine. Am. J. Physiol. Endocrinol. Metab
282(5):E1092–101</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11934675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X, Proud CG. 2006. 
The mTOR pathway in the control of protein synthesis. Physiology
21(5):362–69</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16990457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nygren J, Nair KS. 2003. 
Differential regulation of protein dynamics in splanchnic and skeletal muscle beds by insulin and amino acids in healthy human subjects. Diabetes
52(6):1377–85</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12765947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>James HA, O’Neill BT, Nair KS. 2017. 
Insulin regulation of proteostasis and clinical implications. Cell Metab
26(2):310–23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28712655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rooyackers OE, Nair KS. 1997. 
Hormonal regulation of human muscle protein metabolism. Annu. Rev. Nutr
17(1):457–85</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9240936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biolo G, Tipton KD, Klein S, Wolfe RR. 1997. 
An abundant supply of amino acids enhances the metabolic effect of exercise on muscle protein. Am. J. Physiol. Endocrinol. Metab
273(1):E122–29</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9252488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shad BJ, Thompson JL, Breen L. 2016. 
Does the muscle protein synthetic response to exercise and amino acid-based nutrition diminish with advancing age? A systematic review. Am. J. Physiol. Endocrinol. Metab
311(5):E803–17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27555299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stokes T, Hector A, Morton R, McGlory C, Phillips S. 2018. 
Recent perspectives regarding the role of dietary protein for the promotion of muscle hypertrophy with resistance exercise training. Nutrients
10(2):180</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5852756</ArticleId>
            <ArticleId IdType="pubmed">29414855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fryburg DA, Barrett EJ, Louard RJ, Gelfand RA. 1990. 
Effect of starvation on human muscle protein metabolism and its response to insulin. Am. J. Physiol. Endocrinol. Metab
259(4):E477–82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2221049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castellino P, Luzi L, Simonson DC, Haymond M, DeFronzo RA. 1987. 
Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis. J. Clin. Investig
80(6):1784–93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC442454</ArticleId>
            <ArticleId IdType="pubmed">3316280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holeček M, Šprongl L, Skopec F, Andrýs C, Pecka M. 1997. 
Leucine metabolism in TNF-α and endotoxin-treated rats: contribution of hepatic tissue. Am. J. Physiol. Endocrinol. Metab
273(6):E1052–58</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9435518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riis ALD, Jørgensen JOL, Gjedde S, Nørrelund H, Jurik AG, et al.
2005. 
Whole body and forearm substrate metabolism in hyperthyroidism: evidence of increased basal muscle protein breakdown. Am. J. Physiol. Endocrinol. Metab
288(6):E1067–73</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15657093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riis ALD, Jørgensen JOL, Ivarsen P, Frystyk J, Weeke J, Møller N. 2008. 
Increased protein turnover and proteolysis is an early and primary feature of short-term experimental hyperthyroidism in healthy women. J. Clin. Endocrinol. Metab
93(10):3999–4005</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18628521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi R, Shimomura Y, Otsuka M, Popov KM, Harris RA. 2000. 
Experimental hyperthyroidism causes inactivation of the branched-chain α-ketoacid dehydrogenase complex in rat liver. Arch. Biochem. Biophys
375(1):55–61</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10683248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>el-Khoury AE, Forslund A, Olsson R, Branth S, Sjodin A, et al.
1997. 
Moderate exercise at energy balance does not affect 24-h leucine oxidation or nitrogen retention in healthy men. Am. J. Physiol. Endocrinol. Metab
273(2):E394–407</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9277394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phillips SM, Atkinson SA, Tarnopolsky MA, MacDougall JD. 1993. 
Gender differences in leucine kinetics and nitrogen balance in endurance athletes. J. Appl. Physiol
75(5):2134–41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8307870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wagenmakers AJM, Brookes JH, Coakley JH, Reilly T, Edwards RHT. 1989. 
Exercise-induced activation of the branched-chain 2-oxo acid dehydrogenase in human muscle. Eur. J. Appl. Physiol. Occupat. Physiol
59(3):159–67</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2583157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>White TP, Brooks GA. 1981. 
[U-14C]-glucose, -alanine, and -leucine oxidation in rats at rest and two intensities of running. Am. J. Physiol. Endocrinol. Metab
240(2):E155–65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6781361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McKenzie S, Phillips SM, Carter SL, Lowther S, Gibala MJ, Tarnopolsky MA. 2000. 
Endurance exercise training attenuates leucine oxidation and BCOAD activation during exercise in humans. Am. J. Physiol. Endocrinol. Metab
278(4):E580–87</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10751189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamadeh MJ, Devries MC, Tarnopolsky MA. 2005. 
Estrogen supplementation reduces whole body leucine and carbohydrate oxidation and increases lipid oxidation in men during endurance exercise. J. Clin. Endocrinol. Metab
90(6):3592–99</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15755861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Overmyer K, Evans C, Qi N, Minogue C, Carson J, et al.
2015. 
Maximal oxidative capacity during exercise is associated with skeletal muscle fuel selection and dynamic changes in mitochondrial protein acetylation. Cell Metab
21(3):468–78</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4350023</ArticleId>
            <ArticleId IdType="pubmed">25738461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dohm GL, Hecker AL, Brown WE, Klain GJ, Puente FR, et al.
1977. 
Adaptation of protein metabolism to endurance training. Biochem. J
164:705–8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1164850</ArticleId>
            <ArticleId IdType="pubmed">883961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hatazawa Y, Tadaishi M, Nagaike Y, Morita A, Ogawa Y, et al.
2014. 
PGC-1α-mediated branched-chain amino acid metabolism in the skeletal muscle. PLOS ONE
9(3):e91006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3956461</ArticleId>
            <ArticleId IdType="pubmed">24638054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hatazawa Y, Senoo N, Tadaishi M, Ogawa Y, Ezaki O, et al.
2015. 
Metabolomic analysis of the skeletal muscle of mice overexpressing PGC-1α. PLOS ONE
10(6):e0129084.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4482640</ArticleId>
            <ArticleId IdType="pubmed">26114427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neinast MD, Jang C, Hui S, Murashige DS, Chu Q, et al.
2018. 
Quantitative analysis of the whole-body metabolic fate of branched-chain amino acids. Cell Metab
In press</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6365191</ArticleId>
            <ArticleId IdType="pubmed">30449684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hutson S, Wallin R, Hall T. 1992. 
Identification of mitochondrial branched chain aminotransferase and its isoforms in rat tissues. J. Biol. Chem
267(22):15681–86</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1639805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding C, Li Y, Guo F, Jiang Y, Ying W, et al.
2016. 
A cell-type-resolved liver proteome. Mol. Cell. Proteom
15(10):3190–202</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5054343</ArticleId>
            <ArticleId IdType="pubmed">27562671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palacín M, Estévez R, Bertran J, Zorzano A. 1998. 
Molecular biology of mammalian plasma membrane amino acid transporters. Physiol. Rev
78(4):969–1054</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9790568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. 1998. 
Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J. Biol. Chem
273(37):23629–32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9726963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mastroberardino L, Spindler B, Pfeiffer R, Skelly PJ, Loffing J, et al.
1998. 
Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family. Nature
395(6699):288–91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9751058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oxender DL, Christensen HN. 1963. 
Distinct mediating systems for the transport of neutral amino acids by the Ehrlich cell. J. Biol. Chem
238(11):3686–99</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14109206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verrey F
2003. 
System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflügers Arch
445(5):529–33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12634921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newgard CB. 2012. 
Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab
15(5):606–14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3695706</ArticleId>
            <ArticleId IdType="pubmed">22560213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith QR, Momma S, Aoyagi M, Rapoport SI. 1987. 
Kinetics of neutral amino acid transport across the blood-brain barrier. J. Neurochem
49(5):1651–58</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3668544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gluud LL, Dam G, Les I, Marchesini G, Borre M, et al.
2017. 
Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst. Rev
9:1–83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6481897</ArticleId>
            <ArticleId IdType="pubmed">28518283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silva LS, Poschet G, Nonnenmacher Y, Becker HM, Sapcariu S, et al.
2017. 
Branched-chain ketoacids secreted by glioblastoma cells via MCT1 modulate macrophage phenotype. EMBO Rep
2017:e201744154</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5709768</ArticleId>
            <ArticleId IdType="pubmed">29066459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harper Alfred E
1989. 
Chairman’s remarks: thoughts on the role of branched-chain α-keto acid dehydrogenase complex in nitrogen metabolism. Ann. N.Y. Acad. Sci
573(1):267–73</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2699400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nurjhan N, Bucci A, Perriello G, Stumvoll M, Dailey G, et al.
1995. 
Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man. J. Clin. Investig
95(1):272–77</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC295425</ArticleId>
            <ArticleId IdType="pubmed">7814625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haymond MW, Miles JM. 1982. 
Branched chain amino acids as a major source of alanine nitrogen in man. Diabetes
31(1):86–89</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7152124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Odessey R, Khairallah EA, Goldberg AL. 1974. 
Origin and possible significance of alanine production by skeletal muscle. J. Biol. Chem
249(23):7623–29</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4436328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stumvoll M, Meyer C, Perriello G, Kreider M, Welle S, Gerich J. 1998. 
Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. Am. J. Physiol. Endocrinol. Metab
274(5):E817–26</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9612239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sperringer JE, Addington A, Hutson SM. 2017. 
Branched-chain amino acids and brain metabolism. Neurochem. Res
42(6):1697–709</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28417264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dancis J, Levitz M, Miller S, Westall RG. 1959. 
Maple syrup urine disease. Br. Med. J
1(5114):90–91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1992202</ArticleId>
            <ArticleId IdType="pubmed">13608087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menkes JH. 1959. 
Maple syrup disease: isolation and identification of organic acids in the urine. Pediatrics
23(2):348–53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13633350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menkes JH, Hurst PL, Craig JM. 1954. 
A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance. Pediatrics
14(5):462–67</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13214961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schadewaldt P, Bodner-Leidecker A, Hammen H-W, Wendel U. 1999. 
Significance of l-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin. Chem
45(10):1734–40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10508118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Podebrad F, Heil M, Reichert S, Mosandl A, Sewell A, Böhles H. 1999. 
4,5-Dimethyl-3-hydroxy-2[5H]-furanone (sotolone)—the odour of maple syrup urine disease. J. Inherit. Metab. Dis
22(2):107–14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10234605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sewell AC, Mosandl A, Böhles H. 1999. 
False diagnosis of maple syrup urine disease owing to ingestion of herbal tea. N. Engl. J. Med
341(10):769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10475807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adeva-Andany MM, López-Maside L, Donapetry-García C, Fernández-Fernández C, Sixto-Leal C.2017. 
Enzymes involved in branched-chain amino acid metabolism in humans. Amino Acids
49(6):1005–28</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28324172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yudkoff M
1997. 
Brain metabolism of branched-chain amino acids. Glia
21(1):92–98</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9298851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yudkoff M, Nissim I, Kim S, Pleasure D, Hummeler K, Segal S. 1983. 
[15N] leucine as a source of [15N] glutamate in organotypic cerebellar explants. Biochem. Biophys. Res. Commun
115(1):174–79</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6137216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burrage LC, Nagamani SCS, Campeau PM, Lee BH. 2014. 
Branched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders. Hum. Mol. Genet
23(R1):R1–8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4170715</ArticleId>
            <ArticleId IdType="pubmed">24651065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gambello MJ, Li H. 2018. 
Current strategies for the treatment of inborn errors of metabolism. J. Genet. Genom
45(2):61–70</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29500085</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Díaz VM, Camarena C, de la Vega Á, Martínez-Pardo M, Díaz C, et al.
2014. 
Liver transplantation for classical maple syrup urine disease: long-term follow-up. J. Pediatr. Gastroenterol. Nutr
59(5):636–39</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24979318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barshop BA, Khanna A. 2005. 
Domino hepatic transplantation in maple syrup urine disease. N. Engl. J. Med
353(22):2410–11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16319396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>García-Cazorla A, Oyarzabal A, Fort J, Robles C, Castejón E, et al.
2014. 
Two novel mutations in the BCKDK (branched-chain keto-acid dehydrogenase kinase) gene are responsible for a neurobehavioral deficit in two pediatric unrelated patients. Hum. Mutat
35(4):470–77</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24449431</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Novarino G, El-Fishawy P, Kayserili H, Meguid NA, Scott EM, et al.
2012. 
Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy. Science
338(6105):394–97</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3704165</ArticleId>
            <ArticleId IdType="pubmed">22956686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tčrlungeanu DC, Deliu E, Dotter CP, Kara M, Janiesch PC, et al.
2016. 
Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder. Cell
167(6):1481–94.e18</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5554935</ArticleId>
            <ArticleId IdType="pubmed">27912058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adibi SA. 1968. 
Influence of dietary deprivations on plasma concentration of free amino acids of man. J. Appl. Physiol
25(1):52–57</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5661154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Felig P, Marliss E, Cahill GF. 1969. 
Plasma amino acid levels and insulin secretion in obesity. N. Engl. J. Med
281(15):811–16</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5809519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, et al.
2011. 
Metabolite profiles and the risk of developing diabetes. Nat. Med
17(4):448–53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3126616</ArticleId>
            <ArticleId IdType="pubmed">21423183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, et al.
2009. 
A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab
9(4):311–26</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3640280</ArticleId>
            <ArticleId IdType="pubmed">19356713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu J, Semiz S, van der Lee SJ, van der Spek A, Verhoeven A, et al.
2017. 
Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study. Metabolomics
13(9):104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5533833</ArticleId>
            <ArticleId IdType="pubmed">28804275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guasch-Ferré M, Hruby A, Toledo E, Clish CB, Martínez-González MA, et al.
2016. 
Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care
39(5):833–46</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4839172</ArticleId>
            <ArticleId IdType="pubmed">27208380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lotta LA, Scott RA, Sharp SJ, Burgess S, Luan J, et al.
2016. 
Genetic predisposition to an impaired metabolism of the branched-chain amino acids and risk of type 2 diabetes: a Mendelian randomisation analysis. PLOS Med
13(11):e1002179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5127513</ArticleId>
            <ArticleId IdType="pubmed">27898682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris L-ALS, Smith GI, Patterson BW, Ramaswamy RS, Okunade AL, et al.
2017. 
Alterations in 3-hydroxyisobutyrate and FGF21 metabolism are associated with protein ingestion-induced insulin resistance. Diabetes
66(7):1871–78</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5482083</ArticleId>
            <ArticleId IdType="pubmed">28473464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cummings NE, Williams EM, Kasza I, Konon EN, Schaid MD, et al.
2017. 
Restoration of metabolic health by decreased consumption of branched-chain amino acids: a low BCAA diet restores metabolic health. J. Physiol
596(4):623–45</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5813603</ArticleId>
            <ArticleId IdType="pubmed">29266268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahendran Y, Jonsson A, Have CT, Allin KH, Witte DR, et al.
2017. 
Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels. Diabetologia
60(5):873–78</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28184960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Q, Holmes MV, Davey Smith G, Ala-Korpela M. 2017. 
Genetic support for a causal role of insulin resistance on circulating branched-chain amino acids and inflammation. Diabetes Care
40(12):1779–86</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5701741</ArticleId>
            <ArticleId IdType="pubmed">29046328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herman MA, She P, Peroni OD, Lynch CJ, Kahn BB. 2010. 
Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J. Biol. Chem
285(15):11348–56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2857013</ArticleId>
            <ArticleId IdType="pubmed">20093359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lips MA, Van Klinken JB, van Harmelen V, Dharuri HK, ‘t Hoen PAC, et al.
2014. 
Roux-en-Y gastric bypass surgery, but not calorie restriction, reduces plasma branched-chain amino acids in obese women independent of weight loss or the presence of type 2 diabetes. Diabetes Care
37(12):3150–56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25315204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pietiläinen KH, Naukkarinen J, Rissanen A, Saharinen J, Ellonen P, et al.
2008. 
Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLOS Med
5(3):e51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2265758</ArticleId>
            <ArticleId IdType="pubmed">18336063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sears DD, Hsiao G, Hsiao A, Yu JG, Courtney CH, et al.
2009. 
Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization. PNAS
106(44):18745–50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2763882</ArticleId>
            <ArticleId IdType="pubmed">19841271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ. 2007. 
Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. AJP Endocrinol. Metab
293(6):E1552–63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2767201</ArticleId>
            <ArticleId IdType="pubmed">17925455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wiklund P, Zhang X, Pekkala S, Autio R, Kong L, et al.
2016. 
Insulin resistance is associated with altered amino acid metabolism and adipose tissue dysfunction in normoglycemic women. Sci. Rep
6:24540.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4832240</ArticleId>
            <ArticleId IdType="pubmed">27080554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burrill JS, Long EK, Reilly B, Deng Y, Armitage IM, et al.
2015. 
Inflammation and ER stress regulate branched-chain amino acid uptake and metabolism in adipocytes. Mol. Endocrinol
29(3):411–20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4347289</ArticleId>
            <ArticleId IdType="pubmed">25635940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lo KA, Labadorf A, Kennedy NJ, Han MS, Yap YS, et al.
2013. 
Analysis of in vitro insulin-resistance models and their physiological relevance to in vivo diet-induced adipose insulin resistance. Cell Rep
5(1):259–70</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3874466</ArticleId>
            <ArticleId IdType="pubmed">24095730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsiao G, Chapman J, Ofrecio JM, Wilkes J, Resnik JL, et al.
2011. 
Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats. Am. J. Physiol. Endocrinol. Metab
300(1):E164–74</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3023199</ArticleId>
            <ArticleId IdType="pubmed">20959535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lian K, Du C, Liu Y, Zhu D, Yan W, et al.
2015. 
Impaired adiponectin signaling contributes to disturbed catabolism of branched-chain amino acids in diabetic mice. Diabetes
64(1):49–59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25071024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>White PJ, Lapworth AL, An J, Wang L, McGarrah RW, et al.
2016. 
Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export. Mol. Metab
5(7):538–51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4921791</ArticleId>
            <ArticleId IdType="pubmed">27408778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>White PJ, McGarrah RW, Grimsrud PA, Tso S-C, Yang W-H, et al.
2018. 
The BCKDH kinase and phosphatase integrate BCAA and lipid metabolism via regulation of ATP-citrate lyase. Cell Metab
27(6):1281–93.e7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5990471</ArticleId>
            <ArticleId IdType="pubmed">29779826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeFronzo RA, Tripathy D. 2009. 
Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care
32(Suppl. 2):S157–63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2811436</ArticleId>
            <ArticleId IdType="pubmed">19875544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pedroso J, Zampieri T, Donato J. 2015. 
Reviewing the effects of l-leucine supplementation in the regulation of food intake, energy balance, and glucose homeostasis. Nutrients
7(5):3914–37</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4446786</ArticleId>
            <ArticleId IdType="pubmed">26007339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mardinoglu A, Gogg S, Lotta LA, Stancakova A, Nerstedt A, et al.
2018. 
Elevated plasma levels of 3-hydroxyisobutyric acid are associated with incident type 2 diabetes. EBioMedicine
27:151–55</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5828558</ArticleId>
            <ArticleId IdType="pubmed">29246479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Budhathoki S, Iwasaki M, Yamaji T, Yamamoto H, Kato Y, Tsugane S. 2016. 
Association of plasma concentrations of branched-chain amino acids with risk of colorectal adenoma in a large Japanese population. Ann. Oncol
28(4):818–23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28011449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mayers JR, Wu C, Clish CB, Kraft P, Torrence ME, et al.
2014. 
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat. Med
20(10):1193–98</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4191991</ArticleId>
            <ArticleId IdType="pubmed">25261994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nezami Ranjbar MR, Luo Y, Di Poto C, Varghese RS, Ferrarini A, et al.
2015. 
GC-MS based plasma metabolomics for identification of candidate biomarkers for hepatocellular carcinoma in Egyptian cohort. PLOS ONE
10(6):e0127299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4452085</ArticleId>
            <ArticleId IdType="pubmed">26030804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watanabe A, Higashi T, Sakata T, Nagashima H. 1984. 
Serum amino acid levels in patients with hepatocellular carcinoma. Cancer
54(9):1875–82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6090002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mayers JR, Torrence ME, Danai LV, Papagiannakopoulos T, Davidson SM, et al.
2016. 
Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers. Science
353(6304):1161–65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5245791</ArticleId>
            <ArticleId IdType="pubmed">27609895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bi X, Henry CJ. 2017. 
Plasma-free amino acid profiles are predictors of cancer and diabetes development. Nutr. Diabetes
7(3):e249.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5380892</ArticleId>
            <ArticleId IdType="pubmed">28287627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei J, Xie G, Zhou Z, Shi P, Qiu Y, et al.
2011. 
Salivary metabolite signatures of oral cancer and leukoplakia. Int. J. Cancer
129(9):2207–17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21190195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang IW, Wu WJ, Wang YH, Wu TF, Liang PI, et al.
2015. 
BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder. Histopathology
68(4):520–32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26173071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Y, Yu W, Yang T, Zhang M, Liang C, et al.
2018. 
Overexpression of BCAT1 is a prognostic marker in gastric cancer. Hum. Pathol
75:41–46</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29447920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng YH, Hu WJ, Chen BC, Grahn THM, Zhao YR, et al.
2016. 
BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin. Liver Int
36(12):1836–47</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27246112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tönjes M, Barbus S, Park YJ, Wang W, Schlotter M, et al.
2013. 
BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nat. Med
19(7):901–8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4916649</ArticleId>
            <ArticleId IdType="pubmed">23793099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu W, Yang H, Liu Y, Yang Y, Wang P, et al.
2011. 
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell
19(1):17–30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3229304</ArticleId>
            <ArticleId IdType="pubmed">21251613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, et al.
2017. 
Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature
545(7655):500–4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5554449</ArticleId>
            <ArticleId IdType="pubmed">28514443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oktyabri D, Ishimura A, Tange S, Terashima M, Suzuki T. 2016. 
DOT1L histone methyltransferase regulates the expression of BCAT1 and is involved in sphere formation and cell migration of breast cancer cell lines. Biochimie
123:20–31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26783998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eden A, Simchen G, Benvenisty N. 1996. 
Two yeast homologs of ECA39, a target for c-Myc regulation, code for cytosolic and mitochondrial branched-chain amino acid aminotransferases. J. Biol. Chem
271(34):20242–45</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8702755</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou W, Feng X, Ren C, Jiang X, Liu W, et al.
2013. 
Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma. Mol. Cancer
12(1):53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3698204</ArticleId>
            <ArticleId IdType="pubmed">23758864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raffel S, Falcone M, Kneisel N, Hansson J, Wang W, et al.
2017. 
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation. Nature
551:384–88</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29144447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McBrayer SK, Mayers JR, DiNatale GJ, Shi DD, Khanal J, et al.
2018. 
Transaminase inhibition by 2-hydroxyglutarate impairs glutamate biosynthesis and redox homeostasis in glioma. Cell
175(1):101–16</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6219629</ArticleId>
            <ArticleId IdType="pubmed">30220459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Han J. 2017. 
Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function. Biochem. Biophys. Res. Commun
486(2):224–31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28235484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhattacharya S, Granger CB, Craig D, Haynes C, Bain J, et al.
2014. 
Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization. Atherosclerosis
232(1):191–96</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4784695</ArticleId>
            <ArticleId IdType="pubmed">24401236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah SH, Bain JR, Muehlbauer MJ, Stevens RD, Crosslin DR, et al.
2010. 
Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ. Cardiovasc. Genet
3(2):207–14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20173117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah SH, Sun J-L, Stevens RD, Bain JR, Muehlbauer MJ, et al.
2012. 
Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. Am. Heart J
163(5):844–50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22607863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGarrah RW, Crown SB, Zhang G-F, Shah SH, Newgard CB. 2018. 
Cardiovascular metabolomics. Circ. Res
122(9):1238–58</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6029726</ArticleId>
            <ArticleId IdType="pubmed">29700070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li T, Zhang Z, Kolwicz SC, Abell L, Roe ND, et al.
2017. 
Defective branched-chain amino acid catabolism disrupts glucose metabolism and sensitizes the heart to ischemia-reperfusion injury. Cell Metab
25(2):374–85</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5301464</ArticleId>
            <ArticleId IdType="pubmed">28178567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun H, Olson KC, Gao C, Prosdocimo DA, Zhou M, et al.
2016. 
Catabolic defect of branched-chain amino acids promotes heart failure. Circulation
133(21):2038–49</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4879058</ArticleId>
            <ArticleId IdType="pubmed">27059949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang W, Zhang F, Xia Y, Zhao S, Yan W, et al.
2016. 
Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction. Am. J. Physiol. Heart Circ. Physiol
311(5):H1160–69</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27542406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McNulty PH, Jacob R, Deckelbaum LI, Young LH. 2000. 
Effect of hyperinsulinemia on myocardial amino acid uptake in patients with coronary artery disease. Metab. Clin. Exp
49(10):1365–69</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11079831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwartz RG, Barrett EJ, Francis CK, Jacob R, Zaret BL. 1985. 
Regulation of myocardial amino acid balance in the conscious dog. J. Clin. Investig
75(4):1204–11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC425446</ArticleId>
            <ArticleId IdType="pubmed">2859300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turer AT, Stevens RD, Bain JR, Muehlbauer MJ, van der Westhuizen J, et al.
2009. 
Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. Circulation
119(13):1736–46</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2756963</ArticleId>
            <ArticleId IdType="pubmed">19307475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buse MG, Biggers JF, Friderici KH, Buse JF. 1972. 
Oxidation of branched chain amino acids by isolated hearts and diaphragms of the rat: the effect of fatty acids, glucose, and pyruvate respiration. J. Biol. Chem
247(24):8085–96</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4640937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Jong KA, Lopaschuk GD. 2017. 
Complex energy metabolic changes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction. Can. J. Cardiol
33(7):860–71</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28579160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopaschuk GD. 2017. 
Metabolic modulators in heart disease: past, present, and future. Can. J. Cardiol
33(7):838–49</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28279520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McMullen JR. 2004. 
Inhibition of mTOR signaling with rapamycin regresses established cardiac hyper-trophy induced by pressure overload. Circulation
109(24):3050–55</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15184287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Völkers M, Toko H, Doroudgar S, Din S, Quijada P, et al.
2013. 
Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1. PNAS
110(31):12661–66</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3732982</ArticleId>
            <ArticleId IdType="pubmed">23842089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sciarretta S, Forte M, Frati G, Sadoshima J. 2018. 
New insights into the role of mTOR signaling in the cardiovascular system. Circ. Res
122(3):489–505</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6398933</ArticleId>
            <ArticleId IdType="pubmed">29420210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jackson RH, Singer TP. 1983. 
Inactivation of the 2-ketoglutarate and pyruvate dehydrogenase complexes of beef heart by branched chain keto acids. J. Biol. Chem
258(3):1857–65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6822537</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
